Urokinase-type plasminogen activator receptor: a beacon of malignancy?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18794069.
- Also identified by DOI 10.1158/1078-0432.CCR-08-1557 and PMC identifier 2587046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient care and may provide leads in the development of early detection strategies.
Medical subject headings
- Ovarian Neoplasms